In a Reuters Health story, “Is robot prostate surgery, best for quality of life,” one of the researchers commented on the big push” to promote robotic surgery, and many patients “assume it’s the way to go.” But the researchers say their findings:
“serve as a reminder that popular enthusiasm for robotic prostatectomy merits temperance.”
On PharmaGossip, blogger Jack Friday asks: (Correction: Jack posted it, but it was an op-ed by The Healthcare Channel.)
And, catching up to a Gina Kolata NYT piece of last week, on whether the new health care legislation will impact “chronic overuse of medical care,” there were several gem quotes:
The joke among radiologists, said Dr. Howard P. Forman, a radiologist and health services researcher at Yale, is that “the indication for getting a head CT after a car accident is if you have a head.”
“The minute you attack overutilization you will be called a Nazi before the day is out,” said Uwe E. Reinhardt, a health economist at Princeton.
Opinions on other issues in news, journals, PR, advertising, marketing
Puleeeeease... this 'game changer' weight loss drug causes more nausea and vomiting than a placebo. Some game, some change. My friend Gary would spank you for using the eighth word medical reporters should never, ever use. @garyschwitzer @thackerpd
https://www.healthnewsreview.org/toolkit/just-journalists-writing-tips-case-studies/7-words-and-more-you-shouldnt-use-in-medical-news/ https://twitter.com/OttawaCitizen/status/1361426796126830597
A scary @statnews Op-Ed warns that govt attempts to rein in Pharma may cut off access to "life-changing" drugs.
It takes @garyschwitzer to let us know: the author spent 10 years as Pfizer's public-policy chief. https://twitter.com/garyschwitzer/status/1360325022578053123
.@TranspariMED criticizes STAT op-ed for not disclosing pharma funding of author’s institute - similar to criticism we’ve made of STAT op-eds in the past. @transparify @ThinkTankWatch @icer_review https://www.healthnewsreview.org/2021/02/transparency-watchdog-criticizes-stats-non-disclosure-on-pro-pharma-op-ed/
Comments (2)
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Gerri Shaftel Constant
April 5, 2010 at 5:07 pmIt’s good to see more info coming out about realities of robotic surgery. Some surgeons love the new technology, –it’s fun, like a video game– but having watched robotic heart surgery, I’d be very cautious before getting it. Equipment snafus caused the surgery I watched to last longer than conventional heart surgery. It also felt a bit strange watching a software engineer in the o.r. guide the surgeon through each step of the surgery. All that said the patient who had the surgery recovered just fine. But yikes! I’d have had more faith in the surgeons hands.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like